Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Autoimmune Disorders01:29

Autoimmune Disorders

2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.8K
Overview
84.8K
T Cell Types and Functions01:24

T Cell Types and Functions

2.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phytogenic and natural immunostimulants in the prevention of Lactococcus garvieae infection: an eco-friendly approach.

Veterinary research communications·2026
Same author

The Effect of Carnosine Supplementation on Depressive Symptoms and Health-Related Quality of Life in Individuals With Prediabetes and Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial.

Food science & nutrition·2026
Same author

Prognostic Factors of <i>Staphylococcus aureus</i> Bloodstream Infection in ICU Patients and Establishment of a Prediction Model.

British journal of hospital medicine (London, England : 2005)·2026
Same author

Pyridoxal 5'-Phosphate Suppresses Growth of Pancreatic Adenocarcinoma Cells In Vitro via Regulation of Oncogenic RAS.

Molecular nutrition & food research·2026
Same author

Efficacy of Nurse-Led and Multidisciplinary Self-Management Programmes for Heart Failure with Reduced Ejection Fraction: An Umbrella Systematic Review.

Biomedicines·2025
Same author

Control measures for neglected tropical diseases: vaccine updates.

Expert review of vaccines·2025

Related Experiment Video

Updated: Feb 27, 2026

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

11.0K

Multiple Sclerosis: Immunopathology and Treatment Update.

Narges Dargahi1, Maria Katsara2, Theodore Tselios3

  • 1Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne VIC 3030, Australia. narges.dargahi@live.vu.edu.au.

Brain Sciences
|July 8, 2017
PubMed
Summary

Multiple sclerosis (MS) treatments primarily target relapsing forms, leaving progressive MS challenging. Understanding MS immunopathophysiology is key to developing new therapies and improving adherence for existing disease-modifying treatments.

Keywords:
drug deliveryimmunotherapymultiple sclerosisvaccine

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Related Experiment Videos

Last Updated: Feb 27, 2026

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

11.0K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Area of Science:

  • Neuroimmunology
  • Pharmacology
  • Translational Medicine

Background:

  • Multiple sclerosis (MS) treatment has evolved significantly over two decades, yet progressive forms remain a therapeutic challenge.
  • Current disease-modifying therapies (DMTs) for relapsing-remitting MS (RRMS), such as injectable beta-interferons and glatiramer acetate, face poor adherence, with ~50% of patients discontinuing within a year.
  • A deeper understanding of MS immunopathophysiology is crucial for advancing treatment strategies.

Purpose of the Study:

  • To review the current landscape of MS treatments, including established DMTs and emerging immunomodulatory approaches.
  • To explore the underlying immunopathophysiology of MS to identify targets for novel therapeutic development.
  • To address the unmet need for effective treatments for progressive MS and improve adherence to existing therapies.

Main Methods:

  • Comprehensive review of current and emerging therapeutic strategies for multiple sclerosis.
  • Analysis of the immunopathophysiology of MS to inform drug development.
  • Synthesis of information on injectable DMTs, monoclonal antibodies, and novel immune-modulating approaches.

Main Results:

  • Established injectable DMTs (interferons, glatiramer acetate) and oral agents (dimethyl fumarate, teriflunomide) are primarily for RRMS.
  • Humanized monoclonal antibodies (natalizumab, ocrelizumab, etc.) offer advanced options, targeting specific immune pathways.
  • Emerging strategies like stem cell therapy, DNA vaccines, nanoparticles, and altered peptide ligands show promise for future MS treatment.

Conclusions:

  • Significant progress has been made in treating relapsing forms of MS, but progressive MS requires further research and development.
  • Improving patient adherence to existing therapies and exploring novel immunomodulatory approaches are critical for comprehensive MS management.
  • A foundational understanding of MS immunopathophysiology is essential for the rational design of next-generation therapies.